Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats. 2017

Emilio Russo, and Antonio Leo, and Francesca Scicchitano, and Annalidia Donato, and Edoardo Ferlazzo, and Sara Gasparini, and Vittoria Cianci, and Chiara Mignogna, and Giuseppe Donato, and Rita Citraro, and Umberto Aguglia, and Giovambattista De Sarro
Science of Health Department, School of Medicine, University "Magna Graecia" of Catanzaro, Italy. Electronic address: erusso@unicz.it.

The link between cerebral small vessel disease (CSVD) and epilepsy has been poorly investigated. Some reports suggest that CSVD may predispose to temporal lobe epilepsy (TLE). Aim of this study was to evaluate whether spontaneously hypertensive rats (SHRs), an established model of systemic hypertension and CSVD, have a propensity to develop TLE more than generalized seizures. To this aim, amygdala kindling, as a model of TLE, and pentylenetetrazole (PTZ)-induced kindling, as a model of generalized seizures, have been used to ascertain whether SHRs are more prone to TLE as compared to Wistar Kyoto control rats. While young SHRs (without CSVD) do not differ from their age-matched controls in both models, old SHRs (with CSVD) develop stage 5 seizures in the amygdala kindling model (TLE) faster than age-matched control rats without CSVD. At odds, no differences between old SHRs and age-matched controls was observed in the development of PTZ kindling. Enalapril pre-treatment prevented the development of CSVD and normalized kindling development to control levels in SHRs. No difference was observed in the response to pharmacological treatment with carbamazepine or losartan. Overall, our study suggests that uncontrolled hypertension leading to CSVD might represent a risk factor for TLE. Further experimental studies are needed to unravel other risk factors that, along with CSVD, may predispose to TLE.

UI MeSH Term Description Entries
D008297 Male Males
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D011921 Rats, Inbred WKY A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats (SHR). Rats, Wistar Kyoto,Wistar Kyoto Rat,Rats, WKY,Inbred WKY Rat,Inbred WKY Rats,Kyoto Rat, Wistar,Rat, Inbred WKY,Rat, WKY,Rat, Wistar Kyoto,WKY Rat,WKY Rat, Inbred,WKY Rats,WKY Rats, Inbred,Wistar Kyoto Rats
D004558 Electric Stimulation Use of electric potential or currents to elicit biological responses. Stimulation, Electric,Electrical Stimulation,Electric Stimulations,Electrical Stimulations,Stimulation, Electrical,Stimulations, Electric,Stimulations, Electrical
D004833 Epilepsy, Temporal Lobe A localization-related (focal) form of epilepsy characterized by recurrent seizures that arise from foci within the TEMPORAL LOBE, most commonly from its mesial aspect. A wide variety of psychic phenomena may be associated, including illusions, hallucinations, dyscognitive states, and affective experiences. The majority of complex partial seizures (see EPILEPSY, COMPLEX PARTIAL) originate from the temporal lobes. Temporal lobe seizures may be classified by etiology as cryptogenic, familial, or symptomatic. (From Adams et al., Principles of Neurology, 6th ed, p321). Epilepsy, Benign Psychomotor, Childhood,Benign Psychomotor Epilepsy, Childhood,Childhood Benign Psychomotor Epilepsy,Epilepsy, Lateral Temporal,Epilepsy, Uncinate,Epilepsies, Lateral Temporal,Epilepsies, Temporal Lobe,Epilepsies, Uncinate,Lateral Temporal Epilepsies,Lateral Temporal Epilepsy,Temporal Lobe Epilepsies,Temporal Lobe Epilepsy,Uncinate Epilepsies,Uncinate Epilepsy
D000679 Amygdala Almond-shaped group of basal nuclei anterior to the INFERIOR HORN OF THE LATERAL VENTRICLE of the TEMPORAL LOBE. The amygdala is part of the limbic system. Amygdaloid Body,Amygdaloid Nuclear Complex,Amygdaloid Nucleus,Archistriatum,Corpus Amygdaloideum,Intercalated Amygdaloid Nuclei,Massa Intercalata,Nucleus Amygdalae,Amygdalae, Nucleus,Amygdaloid Bodies,Amygdaloid Nuclear Complices,Amygdaloid Nuclei, Intercalated,Amygdaloid Nucleus, Intercalated,Amygdaloideum, Corpus,Amygdaloideums, Corpus,Archistriatums,Complex, Amygdaloid Nuclear,Complices, Amygdaloid Nuclear,Corpus Amygdaloideums,Intercalata, Massa,Intercalatas, Massa,Intercalated Amygdaloid Nucleus,Massa Intercalatas,Nuclear Complex, Amygdaloid,Nuclear Complices, Amygdaloid,Nuclei, Intercalated Amygdaloid,Nucleus, Amygdaloid,Nucleus, Intercalated Amygdaloid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012640 Seizures Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or "seizure disorder." Absence Seizure,Absence Seizures,Atonic Absence Seizure,Atonic Seizure,Clonic Seizure,Complex Partial Seizure,Convulsion,Convulsions,Convulsive Seizure,Convulsive Seizures,Epileptic Seizure,Epileptic Seizures,Generalized Absence Seizure,Generalized Tonic-Clonic Seizures,Jacksonian Seizure,Myoclonic Seizure,Non-Epileptic Seizure,Nonepileptic Seizure,Partial Seizure,Seizure,Seizures, Convulsive,Seizures, Focal,Seizures, Generalized,Seizures, Motor,Seizures, Sensory,Tonic Clonic Seizure,Tonic Seizure,Tonic-Clonic Seizure,Atonic Absence Seizures,Atonic Seizures,Clonic Seizures,Complex Partial Seizures,Convulsion, Non-Epileptic,Generalized Absence Seizures,Myoclonic Seizures,Non-Epileptic Seizures,Nonepileptic Seizures,Partial Seizures,Petit Mal Convulsion,Seizures, Auditory,Seizures, Clonic,Seizures, Epileptic,Seizures, Gustatory,Seizures, Olfactory,Seizures, Somatosensory,Seizures, Tonic,Seizures, Tonic-Clonic,Seizures, Vertiginous,Seizures, Vestibular,Seizures, Visual,Single Seizure,Tonic Seizures,Tonic-Clonic Seizures,Absence Seizure, Atonic,Absence Seizure, Generalized,Absence Seizures, Atonic,Absence Seizures, Generalized,Auditory Seizure,Auditory Seizures,Clonic Seizure, Tonic,Clonic Seizures, Tonic,Convulsion, Non Epileptic,Convulsion, Petit Mal,Convulsions, Non-Epileptic,Focal Seizure,Focal Seizures,Generalized Seizure,Generalized Seizures,Generalized Tonic Clonic Seizures,Generalized Tonic-Clonic Seizure,Gustatory Seizure,Gustatory Seizures,Motor Seizure,Motor Seizures,Non Epileptic Seizure,Non Epileptic Seizures,Non-Epileptic Convulsion,Non-Epileptic Convulsions,Olfactory Seizure,Olfactory Seizures,Partial Seizure, Complex,Partial Seizures, Complex,Seizure, Absence,Seizure, Atonic,Seizure, Atonic Absence,Seizure, Auditory,Seizure, Clonic,Seizure, Complex Partial,Seizure, Convulsive,Seizure, Epileptic,Seizure, Focal,Seizure, Generalized,Seizure, Generalized Absence,Seizure, Generalized Tonic-Clonic,Seizure, Gustatory,Seizure, Jacksonian,Seizure, Motor,Seizure, Myoclonic,Seizure, Non-Epileptic,Seizure, Nonepileptic,Seizure, Olfactory,Seizure, Partial,Seizure, Sensory,Seizure, Single,Seizure, Somatosensory,Seizure, Tonic,Seizure, Tonic Clonic,Seizure, Tonic-Clonic,Seizure, Vertiginous,Seizure, Vestibular,Seizure, Visual,Seizures, Generalized Tonic-Clonic,Seizures, Nonepileptic,Sensory Seizure,Sensory Seizures,Single Seizures,Somatosensory Seizure,Somatosensory Seizures,Tonic Clonic Seizures,Tonic-Clonic Seizure, Generalized,Tonic-Clonic Seizures, Generalized,Vertiginous Seizure,Vertiginous Seizures,Vestibular Seizure,Vestibular Seizures,Visual Seizure,Visual Seizures
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D059345 Cerebral Small Vessel Diseases Pathological processes or diseases where cerebral MICROVESSELS show abnormalities. They are often associated with aging, hypertension and risk factors for lacunar infarcts (see LACUNAR INFARCTION); LEUKOARAIOSIS; and CEREBRAL HEMORRHAGE. Cerebral Microangiopathies,Cerebral Small Vessel Disease,Cerebral Microangiopathy,Microangiopathies, Cerebral,Microangiopathy, Cerebral

Related Publications

Emilio Russo, and Antonio Leo, and Francesca Scicchitano, and Annalidia Donato, and Edoardo Ferlazzo, and Sara Gasparini, and Vittoria Cianci, and Chiara Mignogna, and Giuseppe Donato, and Rita Citraro, and Umberto Aguglia, and Giovambattista De Sarro
January 1978, Advances in neurology,
Emilio Russo, and Antonio Leo, and Francesca Scicchitano, and Annalidia Donato, and Edoardo Ferlazzo, and Sara Gasparini, and Vittoria Cianci, and Chiara Mignogna, and Giuseppe Donato, and Rita Citraro, and Umberto Aguglia, and Giovambattista De Sarro
October 2023, European journal of neurology,
Emilio Russo, and Antonio Leo, and Francesca Scicchitano, and Annalidia Donato, and Edoardo Ferlazzo, and Sara Gasparini, and Vittoria Cianci, and Chiara Mignogna, and Giuseppe Donato, and Rita Citraro, and Umberto Aguglia, and Giovambattista De Sarro
October 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
Emilio Russo, and Antonio Leo, and Francesca Scicchitano, and Annalidia Donato, and Edoardo Ferlazzo, and Sara Gasparini, and Vittoria Cianci, and Chiara Mignogna, and Giuseppe Donato, and Rita Citraro, and Umberto Aguglia, and Giovambattista De Sarro
January 2021, Frontiers in neurology,
Emilio Russo, and Antonio Leo, and Francesca Scicchitano, and Annalidia Donato, and Edoardo Ferlazzo, and Sara Gasparini, and Vittoria Cianci, and Chiara Mignogna, and Giuseppe Donato, and Rita Citraro, and Umberto Aguglia, and Giovambattista De Sarro
July 2002, Brain pathology (Zurich, Switzerland),
Emilio Russo, and Antonio Leo, and Francesca Scicchitano, and Annalidia Donato, and Edoardo Ferlazzo, and Sara Gasparini, and Vittoria Cianci, and Chiara Mignogna, and Giuseppe Donato, and Rita Citraro, and Umberto Aguglia, and Giovambattista De Sarro
April 2008, Brain research,
Emilio Russo, and Antonio Leo, and Francesca Scicchitano, and Annalidia Donato, and Edoardo Ferlazzo, and Sara Gasparini, and Vittoria Cianci, and Chiara Mignogna, and Giuseppe Donato, and Rita Citraro, and Umberto Aguglia, and Giovambattista De Sarro
January 1984, Journal of cardiovascular pharmacology,
Emilio Russo, and Antonio Leo, and Francesca Scicchitano, and Annalidia Donato, and Edoardo Ferlazzo, and Sara Gasparini, and Vittoria Cianci, and Chiara Mignogna, and Giuseppe Donato, and Rita Citraro, and Umberto Aguglia, and Giovambattista De Sarro
January 1969, Transactions of the American Neurological Association,
Emilio Russo, and Antonio Leo, and Francesca Scicchitano, and Annalidia Donato, and Edoardo Ferlazzo, and Sara Gasparini, and Vittoria Cianci, and Chiara Mignogna, and Giuseppe Donato, and Rita Citraro, and Umberto Aguglia, and Giovambattista De Sarro
February 2011, Epilepsy & behavior : E&B,
Emilio Russo, and Antonio Leo, and Francesca Scicchitano, and Annalidia Donato, and Edoardo Ferlazzo, and Sara Gasparini, and Vittoria Cianci, and Chiara Mignogna, and Giuseppe Donato, and Rita Citraro, and Umberto Aguglia, and Giovambattista De Sarro
January 1981, Acta neuropathologica. Supplementum,
Copied contents to your clipboard!